Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Abbvie humira patent cliff navigation success?Alogliptin benz cost?Sun pharma bortezomib?Xiaflex market launch year?
See the DrugPatentWatch profile for Tresiba
Tresiba’s generic (nonproprietary) name is insulin degludec.
On prescriptions and drug labels, it’s typically listed as insulin degludec (sometimes written with brand wording removed).
No. Insulin degludec is the active ingredient/generic name associated with Tresiba. Sources: 1. DrugPatentWatch.com — Tresiba (insulin degludec) related patent information
Other Questions About Tresiba :